Drugs and Devices

FDA approves new drugs for diabetes

On Sept. 25, the U.S. Food and Drug Administration (FDA) approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve glucose control in adults with diabetes mellitus. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares